Page last updated: 2024-08-24

plerixafor and fosbretabulin

plerixafor has been researched along with fosbretabulin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jiang, J; Li, G; Sakurai, K; Shen, N; Song, W; Tang, Z; Yu, H	1

Other Studies

1 other study(ies) available for plerixafor and fosbretabulin

Article	Year
Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously. Biomaterials science, 2019, Dec-01, Volume: 7, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Breast Neoplasms; Cell Proliferation; Cell Survival; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Receptors, CXCR4; Stilbenes; Theranostic Nanomedicine; Up-Regulation; Xenograft Model Antitumor Assays	2019

Article

Year

Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously.

Biomaterials science, 2019, Dec-01, Volume: 7, Issue:12

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Breast Neoplasms; Cell Proliferation; Cell Survival; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Receptors, CXCR4; Stilbenes; Theranostic Nanomedicine; Up-Regulation; Xenograft Model Antitumor Assays

2019